OVASCIENCE
The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience's proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women's own cellular energy to improve egg quality. OvaScience was co-founded by Richard Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal M.D., Ph.D., of Longwood Founders Fund, along with fertility exper... t and Harvard Medical School Professor Jonathan Tilly, Ph.D. of Massachusetts General Hospital, and aging expert and Harvard Medical School Professor David Sinclair, Ph.D. The company is backed by leading life science investors Longwood Founders Fund and Bessemer Venture Partners. The company has assembled a world-class team of leading reproductive endocrinologists, embryologists, scientists and advisers to bring this technology to patients.
OVASCIENCE
Industry:
Biotechnology Health Care Life Science
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.ovascience.com
Total Employee:
51+
Status:
Closed
Contact:
617-902-0682
Email Addresses:
[email protected]
Total Funding:
135.8 M USD
Technology used in webpage:
Google Universal Analytics Font Awesome Domain Not Resolving IPv6 PHP Cloudflare Hosting Cloudflare DNS Apache 2.4 OpenSSL Amazon Elastic Load Balancing Sticky Session
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Longwood Finance Management, LLC
Longwood Finance Management, LLC investment in Series B - OvaScience
Cycad Group
Cycad Group investment in Series B - OvaScience
Hunt BioVentures
Hunt BioVentures investment in Series B - OvaScience
RA Capital Management
RA Capital Management investment in Series B - OvaScience
BB&T
BB&T investment in Series B - OvaScience
General Catalyst
General Catalyst investment in Series B - OvaScience
Official Site Inspections
http://www.ovascience.com
- Host name: 104.21.75.113
- IP address: 104.21.75.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OvaScience"
Our Team — Evascience
As Customer Excellence lead, he was instrumental in building a best-in-class organization under his leadership. He was deeply involved on a Western European Task team on Pharmacy and Adherence Strategies and was invited …See details»
OvaScience - Wikipedia
OvaScience was a publicly traded biotechnology company, focused on female infertility. It was founded in 2011 by Michelle Dipp, Richard Aldrich, Christoph Westphal, Jonathan Tilly, and David Sinclair and is based on scientific work done by Tilly concerning mammalian oogonial stem cells and work on mitochondria by Sinclair. Tilly's work was expectedly met with skepticism, as it warranted a paradigm-shift; however, many labs across the world have been able to reproduce …See details»
OvaScience - Crunchbase Company Profile & Funding
The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience's proprietary technology, exclusively …See details»
OvaScience - VentureRadar
Acquired/Merged (Assumed) "OvaScience is a privately-held fertility company focused on the discovery, development and commercialization of novel treatments for infertility. OvaScience is …See details»
OvaScience - Funding, Financials, Valuation & Investors
OvaScience has raised a total of. obfuscated. in funding over 7 rounds. Their latest funding was raised on Jun 1, 2016 from a Post-IPO Equity round. OvaScience is registered under the ticker …See details»
OvaScience - Craft
OvaScience is a fertility company dedicated to improving treatment options for women. It discovers, develops, and commercializes fertility treatments.See details»
OvaScience - Products, Competitors, Financials, Employees, …
About OvaScience. OvaScience is a biotechnology company focused on the development of fertility treatments within the healthcare sector. The company's main offerings include …See details»
About us - Evascience
Privately-owned Canadian Company Located on the south shore of Montreal, Evascience develops, imports, and distributes high quality standard Natural Health Products, supported …See details»
OvaScience (OVAS) Strengthens Management Team To Support …
Dec 12, 2014 OvaScience (NASDAQ: OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, developing and …See details»
Evascience - Overview, News & Competitors | ZoomInfo.com
Evascience markets, sells and distributes medical device products in Canada and in the US. It will soon launch specialty pharmaceutical, natural products with clinical significance and …See details»
Turmoil at Troubled Fertility Company Ovascience
Karen Weintraub. December 29, 2016. Ovascience, a company that promised to revolutionize fertility by allowing women to succeed in IVF treatments at older ages, is pulling back on its …See details»
OvaScience Announces Business Update
December 21, 2016 04:04 PM Eastern Standard Time. WALTHAM, Mass.-- ( BUSINESS WIRE )--OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, …See details»
Privacy Policy — Evascience
At Evascience, accessible from evascience.ca, one of our main priorities is the privacy of our visitors. ... You have the right to request that we transfer the data that we have collected to …See details»
OvaScience - Case - Faculty & Research - Harvard Business School
In early April 2012, Michelle Dipp, MD, Ph.D, CEO and co-founder of OvaScience, had just received a buyout offer from PG Ventures, a private equit's first promising fertility treatment, …See details»
OvaScience Is Ready To Capitalize On The Growing IVF Market
Feb 15, 2015 About the Company. OvaScience (OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, …See details»
Accueil — Evascience
Tous les produits sont supportés par des études cliniques robustes qui donneront aux professionnels de la santé des options de première ligne et/ou complémentaires dans l’atteinte …See details»
An Ethical and Legal Analysis of Ovascience – A Publicly Traded ...
In May 2015, the first baby created through an emerging ova technology called AUGMENT, was born in Canada. 1 Developed by OvaScience, AUGMENT essentially introduces mitochondria …See details»
Feature: A controversial company offers a new way to make a …
Nov 5, 2015 A controversial fertility company called OvaScience is preoccupied by an enduring mystery in human biology—why eggs fail—and the palpable hope that we can do something …See details»
Products — Evascience
Natural Health Products (NHP)with Robust Clinical Evidence. This NHP section is under review. Great news will be shared very soon! +1 (514) 236-0061. [email protected]. Our …See details»
An Ethical and Legal Analysis of Ovascience - A Publicly Traded ...
Affiliation 1 Assistant Professor, Department of Family Medicine, University of Manitoba and Clinical Ethicist at St. Boniface General Hospital in Winnipeg, Manitoba. This article benefited …See details»